POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

0
Player Avatar pchop123 (80.37) Submitted: 3/7/2013 8:54:08 PM : Outperform Start Price: $5.89 POZN Score: -6.94

oversold for its near term prospects

Featured Broker Partners


Advertisement